Abstract
The outcome of functional ischemic mitral regurgitation and its surgical treatment is influenced by many factors including the severity of the mitral regurgitation, the degree of leaflet tethering, and left ventricular size, function and viability, amongst others. Papillary muscle geometry, function and viability may also affect outcomes in functional ischemic mitral regurgitation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aronson D, Goldsher N, Zukermann R, Kapeliovich M. Ischemic mitral regurgitation and risk of heart failure after myocardial infarction. Arch Intern Med. 2006;166:2362–8.
Grigioni F, Detaint D, Avierinos J-F, Scott C, Tajik J, Enriquez-Sarano M. Contribution of ischemic mitral regurgitation to congestive heart failure after myocardial infarction. J Am Coll Cardiol. 2005;45:260–7.
Lamas GA, Mitchell GF, Flaker GC, Smith SC, Gersh BJ. Clinical significance of mitral regurgitation after acute myocardial infarction. Circulation. 1997;96(3):827–33.
Perez de Isla L. Prognostic significance of functional mitral regurgitation after a first non-ST-segment elevation acute coronary syndrome. Eur Heart J. 2006;27(22):2655.
Chan KMJ, Punjabi PP, Flather M, et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the randomized ischemic mitral evaluation (RIME) trial. Circulation. 2012;126:2502–10.
Fattouch K, Guccione F, Sampognaro R, et al. Efficacy of adding mitral valve annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg. 2009;138:278–85.
Braun J, van de Veire NR, Klautz RJM, et al. Restrictive mitral annuloplasty cures ischemic mitral regurgitation and heart failure. Ann Thorac Surg. 2008;85:430–7.
Mikuckaite L, Vaskelyte J, Radauskaite G, Zaliunas R, Benetis R. Left ventricular remodelling following ischemic mitral valve repair: predictive factors. Scand Cardiovasc J. 2009;43:57–62.
Schroder JN, Williams ML, Hata JA, Muhlbaier LH, Swaminathan M. Impact of mitral valve regurgitation evaluated by intraoperative transoesophageal echocardiography on long term outcomes after coronary artery bypass grafting. Circulation. 2005;112(Suppl I):I-293–8.
Smith PK, Puskas JD, Ascheim DD, et al. Surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med. 2014;371:2178–88.
Grossi EA, Crooke GA, Di Giorgi PL, Schwartz CA. Impact of moderate functional mitral insufficiency in patients undergoing surgical revascularization. Circulation. 2006;114(1):I573.
Di Mauro M, Di Giammarco G, Vitolla G, Contini M. Impact of no-to-moderate mitral regurgitation on late results after isolated coronary artery bypass grafting in patients with ischemic cardiomyopathy. Ann Thorac Surg. 2006;81(6):2128.
Ryden T, Bech-Hanssen O, Brandrup-Wognsen G, Nilsson F, Svensson S, Jeppsson A. The importance of grade 2 ischemic mitral regurgitation in coronary artery bypass grafting. Eur J Cardiothorac Surg. 2001;20:276–81.
Beeri R, Yosefy C, Guerrero L, et al. Early repair of moderate ischemic mitral regurgitation reverses left ventricular remodelling. A functional and molecular study. Circulation. 2007;116(Suppl I):I-288–93.
Goldstein D, Moskowitz AJ, Gelijns AC, et al. Two year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med. 2016;374(4):344–53.
Pu M, Thomas JD, Gillinov AM, Griffin BP, Brunken RC. Importance of ischemic and viable myocardium for patients with chronic ischemic mitral regurgitation and left ventricular dysfunction. Am J Cardiol. 2003;92:862–4.
Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularisation on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–8.
Kim RJ, Wu E, Rafael A, Chen E-L. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.
Kwong RY, Chan AK, Brown KA, et al. Impact of unrecognised myocardial scar detected by cardiac magnetic resonance imaging on event free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733–43.
Braun J, Bax JJ, Versteegh MIM, Voigt PG. Pre-operative left ventricular dimensions predict reverse remodelling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2005;27:847–53.
Ueno T, Sakata R, Iguro Y, et al. Preoperative advanced left ventricular remodelling predisposes to recurrence of ischemic mitral regurgitation with less reverse remodelling. J Heart Valve Dis. 2008;17:36–41.
Hung J, Papakostas L, Tahta SA, Hardy BG. Mechanism of recurrent ischemic mitral regurgitation after annuloplasty. Continued LV remodelling as a moving target. Circulation. 2004;110(Suppl II):II-85–90.
Ciarka A, Braun J, Delgado V, et al. Predictors of mitral regurgitation recurrence in patients with heart failure undergoing mitral annuloplasty. Am J Cardiol. 2010;106:395–401.
Kron IL, Hung J, Overbey JR, et al. Predicitng recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation. J Thorac Cardiovasc Surg. 2015;149:752–61.
Menicanti L, Donato MD, Castelvecchio S, Santambrogio C. Functional ischemic mitral regurgitation in anterior ventricular remodelling: results of surgical ventricular restoration with and without mitral repair. Heart Fail Rev. 2005;9(4):317–27.
Shudo Y, Taniguchi K, Takeda K, et al. Restrictive mitral annuloplasty with or without surgical ventricular restoration in ischemic dilated cardiomyopathy with severe mitral regurgitation. Circulation. 2011;124 Suppl 1:S107–14.
Roshanali F, Mandegar H, Yousefnia MA, Rayatzadeh H, Alaeddini F. A prospective study of predicting factors in ischemic mitral regurgitation recurrence after ring annuloplasty. Ann Thorac Surg. 2007;84:745–9.
Fattouch K, Murana G, Castrovinci S, et al. Mitral valve annuloplasty and papillary muscle relocation oriented by 3-dimensional tranesophagel echocardiography for severe functional mitral regurgitation. J Thorac Cardiovasc Surg. 2012;143:S38–42.
Hvass U, Tapia M, Baron F, Pouzet B. Papillary muscle sling: a new functional approach to mitral repair in patients with ischemic left ventricular dysfunction and functional mitral regurgitation. Ann Thorac Surg. 2003;75:809–11.
Gelsomino S, Lorusso R, Caciolli S, et al. Insights on left ventricular and valvular mechanisms of recurrent ischemic mitral regurgitation after restrictive annuloplasty and coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2008;136(2):507–18.
Kongsaerepong V. Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. Am J Cardiol. 2006;98(4):504.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Chan, K.M.J. (2017). What Determines Outcome of Functional Ischemic Mitral Regurgitation?. In: Chan, K. (eds) Functional Mitral and Tricuspid Regurgitation. Springer, Cham. https://doi.org/10.1007/978-3-319-43510-7_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-43510-7_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43508-4
Online ISBN: 978-3-319-43510-7
eBook Packages: MedicineMedicine (R0)